GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities

Go back to GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
(NASDAQ: GEHC) Delayed: 60.64 --0 (-0%)
Previous Close $60.64    52 Week High
Open $60.64    52 Week Low
Day High $60.64    P/E N/A 
Day Low $60.64    EPS
Volume 7,193